Most listed pharmas re-appoint their CEO at the general meeting day

Published: 2018-03-20 16:22:34

Updated: 2018-03-20 16:22:34

In the Stockholders’ Super General Meeting Day on March 16^th, most CEOs with expired contract were reappointed.

Only did 2 companies – Chong Kun Dang Holdings and Sam Chun Damg Pharm – appoint a new CEO, but 10 pharmaceutical companies including Yuhan Corporation decided to remain their current CEO in office.

20 listed pharmaceutical companies including Yuhan Corporation held the stockholders...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.